New research from the University of Wisconsin-Madison explains why the incurable brain cancer, glioblastoma multiforme (GBM), is highly resistant to current chemotherapies.
Jun 1, 2012
0
0
Cancer researchers have known for well over a century that different tumor types spread only to specific, preferred organs. But no one has been able to determine the mechanisms of organ specific metastasis, the so-called ...
May 29, 2012
0
0
Cancer treatments designed to block the growth of blood vessels were found to increase the number of cancer stem cells in breast tumors in mice, suggesting a possible explanation for why these drugs don't lead to longer survival, ...
Jan 25, 2012
1
0
The chemotherapy drugs required to push a common form of adult leukemia into remission may contribute to DNA damage that can lead to a relapse of the disease in some patients, findings of a new study suggest.
Jan 11, 2012
0
0
A new study from Harvard School of Public Health (HSPH) and University of California, San Francisco, researchers suggests that men with prostate cancer who smoke increase their risk of prostate cancer recurrence and of dying ...
Jun 21, 2011
0
0
Receiving a cancer diagnosis is life-changing and can cause a range of concerns about ongoing health.
May 18, 2024
0
1
Artificial Intelligence researchers have taken a major step forward in using AI in the fight against cancer.
Mar 28, 2024
0
0
Many cancer therapies, in addition to producing numerous side effects, fail to achieve complete tumor remission, partly due to the presence of cancer stem cells, which are difficult to eradicate. These cells can self-renew ...
Jan 31, 2024
0
0
Soy compounds called isoflavones are among the plant-derived compounds that may significantly reduce the risk of breast cancer recurrence or death, according to a new meta-analysis co-directed by investigators from the Johns ...
Jan 10, 2024
0
1
From 2004 to 2019, the risk for recurrence of colorectal cancer (CRC) decreased in patients with stages I to III disease, according to a study published online Nov. 16 in JAMA Oncology to coincide with the annual meeting ...
Nov 28, 2023
0
0
